- Home
- WAVE vs LSB Comparison
WAVE vs LSB Comparison
Compare WAVE & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- LSB
- Stock Information
- Founded
- WAVE 2011
- LSB 2002
- Country
- WAVE Israel
- LSB China
- Employees
- WAVE N/A
- LSB N/A
- Industry
- WAVE Electric Utilities: Central
- LSB
- Sector
- WAVE Utilities
- LSB
- Exchange
- WAVE Nasdaq
- LSB NYSE
- Market Cap
- WAVE 35.0M
- LSB 31.5M
- IPO Year
- WAVE 2021
- LSB N/A
- Fundamental
- Price
- WAVE $6.50
- LSB $1.15
- Analyst Decision
- WAVE Strong Buy
- LSB
- Analyst Count
- WAVE 1
- LSB 0
- Target Price
- WAVE $15.00
- LSB N/A
- AVG Volume (30 Days)
- WAVE 27.7K
- LSB 18.1K
- Earning Date
- WAVE 05-08-2025
- LSB 06-21-2025
- Dividend Yield
- WAVE N/A
- LSB N/A
- EPS Growth
- WAVE N/A
- LSB N/A
- EPS
- WAVE N/A
- LSB N/A
- Revenue
- WAVE $168,000.00
- LSB $79,415,311.00
- Revenue This Year
- WAVE $325.00
- LSB $39.33
- Revenue Next Year
- WAVE $85.71
- LSB $75.61
- P/E Ratio
- WAVE N/A
- LSB N/A
- Revenue Growth
- WAVE N/A
- LSB N/A
- 52 Week Low
- WAVE $2.20
- LSB $1.15
- 52 Week High
- WAVE $17.63
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- WAVE 51.16
- LSB 30.00
- Support Level
- WAVE $6.45
- LSB $1.16
- Resistance Level
- WAVE $7.13
- LSB $1.23
- Average True Range (ATR)
- WAVE 0.54
- LSB 0.08
- MACD
- WAVE 0.09
- LSB 0.03
- Stochastic Oscillator
- WAVE 51.72
- LSB 7.42
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.